Pro Share Advisors LLC Durect Corp Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.38 - $0.64 $16,117 - $27,145	-42,415 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$0.55 - $0.98 $3,853 - $6,865	-7,006 Reduced 14.18%	42,415 $29,000
Q4 2021 Feb 08, 2022	BUY	$0.9 - $1.31 $18,387 - $26,763	20,430 Added 70.47%	49,421 $49,000
Q3 2021 Nov 12, 2021	SELL	$1.21 - $1.61 $35,934 - $47,813	-29,698 Reduced 50.6%	28,991 $37,000
Q2 2021 Aug 13, 2021	SELL	$1.6 - $2.02 $1,444 - $1,824	-903 Reduced 1.52%	58,689 $96,000
Q1 2021 May 14, 2021	BUY	$1.86 - $2.87 $26,313 - $40,601	14,147 Added 31.13%	59,592 $118,000
Q4 2020 Feb 09, 2021	BUY	$1.65 - $2.43 $34,023 - $50,106	20,620 Added 83.06%	45,445 $94,000
Q3 2020 Nov 13, 2020	SELL	$1.6 - $2.35 $3,288 - $4,829	-2,055 Reduced 7.65%	24,825 $42,000
Q2 2020 Aug 03, 2020	BUY	$1.33 - $2.76 $35,750 - $74,188	26,880 New	26,880 $62,000
Q3 2019 Nov 12, 2019	SELL	$0.61 - $2.21 $10,130 - $36,701	-16,607 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$0.51 - $0.86 $222 - $374	-436 Reduced 2.56%	16,607 $11,000
Q1 2019 May 15, 2019	BUY	$0.51 - $0.82 $270 - $434	530 Added 3.21%	17,043 $11,000
Q4 2018 Feb 14, 2019	SELL	$0.48 - $1.1 $1,277 - $2,928	-2,662 Reduced 13.88%	16,513 $8,000
Q3 2018 Nov 14, 2018	SELL	$1.06 - $1.69 $1,560 - $2,487	-1,472 Reduced 7.13%	19,175 $21,000
Q2 2018 Aug 13, 2018	BUY	$1.56 - $2.51 $3,600 - $5,793	2,308 Added 12.59%	20,647 $32,000
Q1 2018 May 14, 2018	SELL	$0.91 - $2.24 $2,691 - $6,625	-2,958 Reduced 13.89%	18,339 $39,000
Q4 2017 Feb 14, 2018	BUY	$0.78 - $2.1 $16,611 - $44,723	21,297 New	21,297 $20,000
Q3 2017 Nov 13, 2017	SELL	$1.55 - $1.82 $18,775 - $22,045	-12,113 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	12,113	12,113 $19,000

Others Institutions Holding DRRX

# of Institutions

Shares Held

593K

Call Options Held

Put Options Held

View Full List

About DURECT CORP

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $189M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

More about DRRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account